[1] |
SHI Zheng-yu, WU Gui-hui, HUANG Tao, LIU Yu-hong, GAO Meng-qiu, CHEN Lei, LI Xi, YANG Ming, HE Wei, CHEN Yan, LU Xiao-li, GAO Jing-tao, LI Liang.
Early effectiveness and safety of bedaquiline containing regimen in treatment of multidrug-resistant and extensively drug-resistant tuberculosis: An one arm observational study of 24 weeks
[J]. Chinese Journal of Antituberculosis, 2021, 43(5): 487-494.
|
[2] |
SHEN Xin, XIAO Xiao, BAI Li-qiong, PAN Qi-chao.
Interpretation of the Guidelines on management of close contacts of active pulmonary tuberculosis cases in schools
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 990-991.
|
[3] |
CHENG Jun.
Interpretation of the Specification of tuberculosis examination for student entrance physical examination
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 987-989.
|
[4] |
ZHANG Can-you, XIA Hui, CHENG Jun.
Testing and reporting requirements for Class Ⅱ biosafety cabinet in tuberculosis laboratory
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 903-909.
|
[5] |
The Group of Osteoarticular Tuberculosis.
Guidelines on surgical treatment of osteoarticular tuberculosis in facing novel coronavirus pneumonia
[J]. Chinese Journal of Antituberculosis, 2020, 42(3): 185-190.
|
[6] |
SUN Ming-lei, GUAN Li, ZHAO Juan, WANG Chen, ZOU Dan-dan, LIANG Li-bo.
Legislative considerations on traffic travel of MDR-TB/XDR-TB patients from the perspective of infectious disease prevention and control
[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1268-1271.
|
[7] |
YING Ruo-yan, HUANG Xiao-chen, WANG Jie, LIU Yi-dian, SHA Wei, YANG Hua.
Clinical analysis of drug sensitivity tests of various drug-resistant MTB isolates against different combinations of anti-tuberculosis drugs in vitro
[J]. Chinese Journal of Antituberculosis, 2020, 42(11): 1183-1182.
|
[8] |
XU Cai-hong, ZHANG Hui, LIU Jian-jun.
Interpretation of the Employees Health Examination Specification-Tuberculosis Examination
[J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1134-1136.
|
[9] |
Shi-wen JIANG,Xiao-qiu LIU.
Interpretation of key points and suggestion for the Health Management Service Specification for Tuberculosis Patients
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 926-929.
|
[10] |
FAN Lin,XIONG Kun-long,XIAO He-ping.
Historic review of anti-tuberculosis chemotherapy during seventy years of the People’s Republic of China
[J]. Chinese Journal of Antituberculosis, 2019, 41(11): 1145-1148.
|
[11] |
Gui-qing HE,Feng SUN,Fei-fei SU,Ji-chan SHI,Hai-yan ZHU,Jian-yi DAI,Shou-feng YANG,Hong-ye NING,Xiao-ya CUI,Qun-hua LI,Xian-gao JIANG,Wen-hong. ZHANG.
Treatment outcomes of the standardized regimens for patients with multildrug-resistant pulmonary tuberculosis in Wenzhou during 2013 to 2015
[J]. Chinese Journal of Antituberculosis, 2018, 40(2): 161-167.
|
[12] |
GUO Xiao-yan, LI Fang, WANG Yu, JIN Jin, SONG Chun-yan.
The effect analysis of building the Shandong standardized county for tuberculosis prevention and control
[J]. Chinese Journal of Antituberculosis, 2012, 34(9): 560-566.
|
[13] |
Lou Hai,Xiao Heping,Zhang Qing,Yan Liping,Yue Jun.
Clinical features of Multidrug-resistant and extensively drug-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2009, 31(11): 653-656.
|